These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12647832)

  • 1. Continuing education.
    Lawrence I
    Diabet Med; 2003 Jan; 20 Suppl 1():1. PubMed ID: 12647832
    [No Abstract]   [Full Text] [Related]  

  • 2. Pioglitazone: the future.
    Brunetti P
    Int J Clin Pract Suppl; 2001 Sep; (121):36. PubMed ID: 11594244
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidance on rosiglitazone for type 2 diabetes mellitus.
    Matthews DR
    Lancet; 2001 Feb; 357(9254):481. PubMed ID: 11273100
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes mellitus. Proceedings of a symposium. November 6-8, 2002, New York, New York, USA.
    Am J Med; 2003 Dec; 115 Suppl 8A():1S-120S. PubMed ID: 14678858
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of diabetic dyslipidemia].
    Rubinstein A; Izhakov E
    Harefuah; 2001 Aug; 140(8):744-6. PubMed ID: 11547480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Infarct prevention for diabetics. To lower blood sugar is not enough].
    MMW Fortschr Med; 2001 Nov; 143(46):61. PubMed ID: 11759608
    [No Abstract]   [Full Text] [Related]  

  • 7. Absolute benefit from cholesterol lowering in diabetic patients with coronary heart disease.
    Strandberg TE
    Diabetes Care; 1997 Sep; 20(9):1495-6. PubMed ID: 9283807
    [No Abstract]   [Full Text] [Related]  

  • 8. Wider role seen for "remarkable" statins. Study suggests that benefits extend even to those with "normal" cholesterol levels.
    Heart Advis; 2002 Jan; 5(1):3. PubMed ID: 16145760
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vascular damage decides prognosis of type 2 diabetic patients. Lowering blood glucose is not enough].
    MMW Fortschr Med; 2002 May; 144(18):65. PubMed ID: 12422717
    [No Abstract]   [Full Text] [Related]  

  • 10. [Life expectancy decreased by 1/3rd. Who to sink the vascular risk of type 2 diabetic patients?].
    MMW Fortschr Med; 2001 Dec; 143(49-50):56. PubMed ID: 11808457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?].
    MMW Fortschr Med; 2003 Sep; 145(38):60. PubMed ID: 14603687
    [No Abstract]   [Full Text] [Related]  

  • 12. [The CARDS Study: cardiovascular primary prevention in diabetes patients using Atorvastin].
    Griebenow R
    Internist (Berl); 2005 Mar; 46(3):350-2. PubMed ID: 15696286
    [No Abstract]   [Full Text] [Related]  

  • 13. [4S [Scandinavian Simvastatin Survival Study]].
    Koizumi J; Yoshida I
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():410-5. PubMed ID: 11347105
    [No Abstract]   [Full Text] [Related]  

  • 14. How effective is simvastatin 10 mg?
    Young J
    Br J Gen Pract; 2003 Apr; 53(489):326-7. PubMed ID: 12879839
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus.
    Constance C; Westphal S; Chung N; Lund M; McCrary Sisk C; Johnson-Levonas AO; Massaad R; Allen C
    Diabetes Obes Metab; 2007 Jul; 9(4):575-84. PubMed ID: 17451425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes drug may also benefit blood vessels.
    Mayo Clin Health Lett; 2003 Nov; 21(11):4. PubMed ID: 14679928
    [No Abstract]   [Full Text] [Related]  

  • 17. Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?
    Sathyapalan T; Atkin SL; Kilpatrick ES
    Diabetes Obes Metab; 2010 Jun; 12(6):540-4. PubMed ID: 20518809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of coronary heart disease in type 2 diabetes.
    Mykkänen L
    Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lipid management in diabetes.
    Ganda OP
    Cardiol Clin; 2005 May; 23(2):153-64, vi. PubMed ID: 15694744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents.
    Dandona P; Aljada A
    J Diabetes Complications; 2004; 18(2):91-102. PubMed ID: 15120703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.